Tyler Kemp, PA
Surgical · Roanoke, VANPI 1801304407
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,255 of the $12,991 with a category attached, or 78.9%. 27 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 24.1% of the total. Reporting peaked in 2024 at $7,208 and has fallen 52.2% since, to $3,443 in 2025. Among surgical clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 303 payments — averaging $42.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$3K
- Abbott$3K
- Nevro Corp.$2K
- Boston Scientific$1K
- Curonix LLC$767
- Collegium Pharmaceutical, Inc.$476
- plus $3K from 21 others
What the payments were for
- Travel & lodging$2,73621%
- Food & beverage$10,25579%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 14 | $3,136 |
| Abbott | 90 | $2,796 |
| Nevro Corp. | 31 | $1,979 |
| Boston Scientific | 19 | $1,073 |
| Curonix LLC | 14 | $767 |
| Collegium Pharmaceutical, Inc. | 40 | $476 |
| AbbVie | 20 | $349 |
| Stryker | 3 | $334 |
| IBSA Pharma Inc. | 12 | $253 |
| Pfizer | 17 | $229 |
| Medtronic | 6 | $202 |
| MML US, Inc. | 1 | $185 |
| Axonics, Inc. | 2 | $149 |
| Globus Medical | 4 | $139 |
| Averitas Pharma Inc. | 6 | $136 |
| Vertex | 6 | $134 |
| Vertos Medical, Inc. | 2 | $131 |
| Si-bone, Inc. | 1 | $130 |
| Merz Pharmaceuticals, LLC | 3 | $76 |
| SPR Therapeutics, Inc | 3 | $69 |
| Foundation Fusion Solutions, LLC | 1 | $59 |
| Johnson & Johnson | 2 | $52 |
| Orthofix Medical, Inc. | 1 | $37 |
| Tersera Therapeutics LLC | 1 | $36 |
| Fortis Surgical, LLC | 2 | $27 |
| Lundbeck LLC | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$2,756
- Senza$1,127
- PROCLAIM$430
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$366
- Intracept$274
- ReActiv8$185
- ETERNA$158
- EVEREST SPINAL SYSTEM$152
- mild Device Kit$151
- Axonics$134
- Intracept RF Probe$134
- Proclaim IPG$112
How this compares
$12,991 in reported general payments places this provider in the 95th percentile of 201 surgical providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 23 | $11,985 |
| Buprenorphine | 26 | $8,472 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 214 | $4,332 |
| Pregabalin | 128 | $2,700 |
| Fentanyl | 19 | $2,694 |
| Oxycodone Hcl | 84 | $2,167 |
| Gabapentin | 136 | $1,260 |
| Tramadol Hcl | 170 | $1,251 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 49 | $1,249 |
| Celecoxib | 22 | $775 |
| Tramadol Hcl ErTramadol Hcl | 11 | $482 |
| Diclofenac Sodium | 20 | $310 |
| Tizanidine Hcl | 30 | $279 |
| Topiramate | 20 | $263 |
| Meloxicam | 50 | $244 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $476 | $11,98523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 201 surgical providers in Virginia.
Other surgical in Roanoke
- Savannah WrightRoanoke$10K
- Katherine DuffRoanoke$4K
- John ConradRoanoke$2K
- Kathryn HoytRoanoke$2K
- Jeanine GargiuloAlexandria$298K
- Kelly LohmannWoodbridge$88K
- Alan FitchRichmond$66K
- Kristin LuptonFairfax$16K
- Rebecca LehmanCharlottesville$11K
- Kathryn RobertsonCharlottesville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.